Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors.
about
A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system.Human T-lymphotropic virus antibody screening of blood donors: rates of false-positive results and evaluation of a potential donor reentry algorithm.Human T-lymphotropic virus and transfusion safety: does one size fit all?Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers.Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms.Antiviral effect of raltegravir on HTLV-1 carriers.
P2860
Q35943022-801CACE1-D86A-4CC0-AB24-69AA3F2ADE8EQ36250371-0B67FEB8-7788-4A5A-923B-AF775E080EB4Q38033652-D88F0312-7342-48C3-B1D6-6121858A6C41Q38414305-8377EE75-1E32-4D6D-8C33-194C6F2787E8Q38590004-AA76C085-D3BF-4CD4-B691-53766A7E4F70Q38940579-4059F1BB-C876-4271-84AA-B2AB95D4D175Q39014284-B81EEC12-F35F-44AC-BB57-AFFD322BFD01Q39220045-41886F11-DE44-4AE3-B758-95FFF7C9A0B4Q39533372-D4CBD2AA-7F48-42B0-8D99-0072D7F98281Q39533380-115452BA-58E4-413C-ADB1-F1E90C5E40F4
P2860
Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Evaluation of the use of real- ...... in screening for blood donors.
@en
Evaluation of the use of real- ...... in screening for blood donors.
@nl
type
label
Evaluation of the use of real- ...... in screening for blood donors.
@en
Evaluation of the use of real- ...... in screening for blood donors.
@nl
prefLabel
Evaluation of the use of real- ...... in screening for blood donors.
@en
Evaluation of the use of real- ...... in screening for blood donors.
@nl
P2093
P2860
P1476
Evaluation of the use of real- ...... in screening for blood donors.
@en
P2093
Anna Bárbara de Freitas Carneiro-Proietti
Fernando Valadares Basques
João Gabriel Ribas
Maria Sueli Silva Namen-Lopes
Marina Lobato Martins
Maísa Aparecida Ribeiro
Rafaela Gomes Andrade
Sônia Mara Nunes Silva
P2860
P304
P356
10.1590/S0037-86822010000200001
P577
2010-03-01T00:00:00Z